BCRX
Price
$4.48
Change
-$0.09 (-1.97%)
Updated
May 2, 6:59 PM EST
4 days until earnings call
GLPG
Price
$29.50
Change
+$0.16 (+0.55%)
Updated
May 2, 2:34 PM EST
Earnings call today
Ad is loading...

BCRX vs GLPG ᐉ Comparison: Which is Better to Invest?

Header iconBCRX vs GLPG Comparison
Open Charts BCRX vs GLPGBanner chart's image
BioCryst Pharmaceuticals
Price$4.48
Change-$0.09 (-1.97%)
Volume$1.48M
CapitalizationN/A
Galapagos
Price$29.50
Change+$0.16 (+0.55%)
Volume$600
CapitalizationN/A
View a ticker or compare two or three
BCRX vs GLPG Comparison Chart

Loading...

BCRXDaily Signal changed days agoGain/Loss if shorted
 
Show more...
GLPGDaily Signal changed days agoGain/Loss if shorted
 
Show more...
VS
BCRX vs. GLPG commentary
May 03, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BCRX is a Hold and GLPG is a Hold.

COMPARISON
Comparison
May 03, 2024
Stock price -- (BCRX: $4.57 vs. GLPG: $29.33)
Brand notoriety: BCRX: Notable vs. GLPG: Not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BCRX: 119% vs. GLPG: 112%
Market capitalization -- BCRX: $942.93M vs. GLPG: $1.87B
BCRX [@Biotechnology] is valued at $942.93M. GLPG’s [@Biotechnology] market capitalization is $1.87B. The market cap for tickers in the [@Biotechnology] industry ranges from $578.54B to $0. The average market capitalization across the [@Biotechnology] industry is $2.62B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BCRX’s FA Score shows that 1 FA rating(s) are green whileGLPG’s FA Score has 0 green FA rating(s).

  • BCRX’s FA Score: 1 green, 4 red.
  • GLPG’s FA Score: 0 green, 5 red.
According to our system of comparison, both BCRX and GLPG are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BCRX’s TA Score shows that 4 TA indicator(s) are bullish while GLPG’s TA Score has 5 bullish TA indicator(s).

  • BCRX’s TA Score: 4 bullish, 3 bearish.
  • GLPG’s TA Score: 5 bullish, 2 bearish.
According to our system of comparison, GLPG is a better buy in the short-term than BCRX.

Price Growth

BCRX (@Biotechnology) experienced а +8.55% price change this week, while GLPG (@Biotechnology) price change was +1.95% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +5.13%. For the same industry, the average monthly price growth was -1.93%, and the average quarterly price growth was +1240.72%.

Reported Earning Dates

BCRX is expected to report earnings on Aug 01, 2024.

GLPG is expected to report earnings on Aug 01, 2024.

Industries' Descriptions

@Biotechnology (+5.13% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
A.I.dvisor published
a Summary for BCRX with price predictions.
OPEN
A.I.dvisor published
a Summary for GLPG with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
GLPG($1.87B) has a higher market cap than BCRX($943M). BCRX YTD gains are higher at: -23.706 vs. GLPG (-27.847).
BCRXGLPGBCRX / GLPG
Capitalization943M1.87B50%
EBITDAN/AN/A-
Gain YTD-23.706-27.84785%
P/E RatioN/AN/A-
RevenueN/AN/A-
Total CashN/AN/A-
Total DebtN/AN/A-
FUNDAMENTALS RATINGS
BCRX vs GLPG: Fundamental Ratings
BCRX
GLPG
OUTLOOK RATING
1..100
5951
VALUATION
overvalued / fair valued / undervalued
1..100
3
Undervalued
94
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
10041
PRICE GROWTH RATING
1..100
8783
P/E GROWTH RATING
1..100
10072
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

BCRX's Valuation (3) in the Biotechnology industry is significantly better than the same rating for GLPG (94). This means that BCRX’s stock grew significantly faster than GLPG’s over the last 12 months.

BCRX's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as GLPG (100). This means that BCRX’s stock grew similarly to GLPG’s over the last 12 months.

GLPG's SMR Rating (41) in the Biotechnology industry is somewhat better than the same rating for BCRX (100). This means that GLPG’s stock grew somewhat faster than BCRX’s over the last 12 months.

GLPG's Price Growth Rating (83) in the Biotechnology industry is in the same range as BCRX (87). This means that GLPG’s stock grew similarly to BCRX’s over the last 12 months.

GLPG's P/E Growth Rating (72) in the Biotechnology industry is in the same range as BCRX (100). This means that GLPG’s stock grew similarly to BCRX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
BCRXGLPG
RSI
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 2 days ago
57%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
86%
Bullish Trend 2 days ago
60%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
70%
MACD
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 2 days ago
58%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
64%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
77%
Advances
ODDS (%)
Bullish Trend 23 days ago
79%
N/A
Declines
ODDS (%)
Bearish Trend 8 days ago
81%
Bearish Trend 3 days ago
77%
BollingerBands
ODDS (%)
N/A
Bullish Trend 2 days ago
68%
Aroon
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 2 days ago
75%
View a ticker or compare two or three
Ad is loading...
BCRXDaily Signal changed days agoGain/Loss if shorted
 
Show more...
GLPGDaily Signal changed days agoGain/Loss if shorted
 
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
TGSAX9.29N/A
N/A
Templeton Global Smaller Comp Adv
AFOYX14.87-0.03
-0.20%
Ariel Focus Institutional
JUEAX22.46-0.06
-0.27%
JPMorgan US Equity A
POEYX10.47-0.03
-0.29%
Principal Origin Emerging Markets A
NEMAX18.30-0.06
-0.33%
Neuberger Berman Emerg Mkts Eq A

BCRX and

Correlation & Price change

A.I.dvisor indicates that over the last year, BCRX has been loosely correlated with NTLA. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if BCRX jumps, then NTLA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BCRX
1D Price
Change %
BCRX100%
+10.65%
NTLA - BCRX
51%
Loosely correlated
+5.14%
VCYT - BCRX
46%
Loosely correlated
+2.86%
FOLD - BCRX
46%
Loosely correlated
+4.30%
XNCR - BCRX
46%
Loosely correlated
+14.28%
BEAM - BCRX
46%
Loosely correlated
+2.45%
More

GLPG and

Correlation & Price change

A.I.dvisor indicates that over the last year, GLPG has been loosely correlated with VCYT. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if GLPG jumps, then VCYT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GLPG
1D Price
Change %
GLPG100%
+3.09%
VCYT - GLPG
43%
Loosely correlated
+2.86%
NTLA - GLPG
39%
Loosely correlated
+5.14%
BCRX - GLPG
37%
Loosely correlated
+10.65%
ACLX - GLPG
36%
Loosely correlated
+4.28%
NRIX - GLPG
36%
Loosely correlated
+8.99%
More